These mice were then treated with tan-CAR T cells, CD19-CAR T cells, BCMA-CAR T cells, or NCs on day 8 and day 10 (Fig. 4a) and tumor growth was monitored by IVIS imaging; representative images depicting tumor progression or elimination are shown in Fig. 4b. The gene discussed is CD19; the disease is neoplasm.